Punjab, April 6 -- PROVIDENCIALES, Turks and Caicos Islands, April 6, 2026 /PRNewswire/ - KuCoin, a leading global crypto platform built on trust, today announced the launch of KuCoin PROOF, one of Ku... Read More
India, April 6 -- This article outlines HSBC's bullish view on ITC Hotels, highlighting a 40 percent upside. It discusses steady Q4 FY26 performance, robust domestic demand offsetting geopolitical cha... Read More
Mumbai, April 6 -- Domestic deposits grew 2.72% YoY to Rs 13,06,297 crore, while rising 6.88% QoQ as of 31 March 2026. Domestic CASA deposits stood at Rs 4,59,988 crore, increasing 7.90% YoY and 10.82... Read More
Dhaka, April 6 -- The construction of a new building for the 100-bed district hospital in Narsingdi has not been completed in eight years. Meanwhile, patient services are being disrupted due to lack o... Read More
Kuala Lampur, April 6 --   LONDON, April 7 - One of the promoters of an annual London music festival yesterday defended plans for Kanye West to headline it, amid a backlash over the US rapp... Read More
India, April 6 -- This Tata Group retail player is in focus as its shares surged 8 percent in today's session, outperforming the broader market after reporting a strong Q4 business update. The rally c... Read More
Mumbai, April 6 -- The bank's global business stood at Rs 30,78,854 crore, registering a growth of 13.93% YoY compared to Rs 27,02,496 crore as of 31 March 2025. Global deposits increased 12.00% YoY t... Read More
Mumbai, April 6 -- Goldiam International has opened its 22nd and 23rd retail stores for lab-grown diamond jewellery under the brand name "ORIGEM" at the following locations, which commenced operation... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More